Groupama Asset Managment Sells 38,640 Shares of Healthpeak Properties, Inc. $DOC

Groupama Asset Managment decreased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 28.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 96,582 shares of the real estate investment trust’s stock after selling 38,640 shares during the period. Groupama Asset Managment’s holdings in Healthpeak Properties were worth $1,850,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in DOC. Mather Group LLC. bought a new stake in Healthpeak Properties during the third quarter worth approximately $25,000. City Holding Co. bought a new position in shares of Healthpeak Properties in the third quarter valued at approximately $26,000. Sound Income Strategies LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at approximately $28,000. Rexford Capital Inc. acquired a new stake in shares of Healthpeak Properties in the second quarter worth $28,000. Finally, Elevation Point Wealth Partners LLC acquired a new stake in shares of Healthpeak Properties in the second quarter worth $32,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Trading Up 2.0%

Shares of Healthpeak Properties stock opened at $17.75 on Friday. Healthpeak Properties, Inc. has a 52-week low of $15.71 and a 52-week high of $20.81. The firm has a market capitalization of $12.34 billion, a PE ratio of 177.47, a price-to-earnings-growth ratio of 9.31 and a beta of 1.12. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82. The company’s fifty day moving average price is $17.25 and its two-hundred day moving average price is $17.56.

Healthpeak Properties (NYSE:DOCGet Free Report) last issued its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The business had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. During the same period in the previous year, the business earned $0.46 EPS. The firm’s revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a c) dividend on an annualized basis and a dividend yield of 6.9%. Healthpeak Properties’s dividend payout ratio is presently 1,220.00%.

Analyst Ratings Changes

A number of research analysts recently issued reports on DOC shares. Evercore lowered their target price on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Jefferies Financial Group lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating and cut their target price for the stock from $21.00 to $17.00 in a research report on Monday, December 15th. The Goldman Sachs Group began coverage on shares of Healthpeak Properties in a report on Friday, January 9th. They set a “neutral” rating and a $17.00 price target for the company. Weiss Ratings raised Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. Finally, Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $19.42.

View Our Latest Report on Healthpeak Properties

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Featured Articles

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.